Feasibility of myelosuppressive chemotherapy in psychiatric patients on clozapine: a systematic review of the literature
Objective Clozapine is the favoured antipsychotic for treatment‐refractory schizophrenia, but
has a 1%‐2% incidence of agranulocytosis. Patients who require chemotherapy therefore …
has a 1%‐2% incidence of agranulocytosis. Patients who require chemotherapy therefore …
Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma
Background: Clozapine remains the antipsychotic of choice for refractory schizophrenia.
Given the particular side effects of clozapine including neutropenia and myelosuppression …
Given the particular side effects of clozapine including neutropenia and myelosuppression …
Maligne bolesti i psihički poremećaji Σ prevalencija, mortalitet, terapijski izazov
Sažetak Psihički poremećaji koji dolaze u komorbiditetu s karcinomom drastično smanjuju
kvalitetu života i utječu na ishod bolesti, povećavaju mortalitet, a prema literaturi smatra se …
kvalitetu života i utječu na ishod bolesti, povećavaju mortalitet, a prema literaturi smatra se …
Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review
Regular monitoring of blood counts ensures the safety of clozapine use; however, certain
clinical situations may pose a dilemma for management such as use of clozapine in the …
clinical situations may pose a dilemma for management such as use of clozapine in the …
[PDF][PDF] Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization
Clozapine is considered a preferred agent for several psychotic disorders and the drug of
choice for treatment-resistant schizophrenia [1]. Clozapine-induced agranulocytosis is rare …
choice for treatment-resistant schizophrenia [1]. Clozapine-induced agranulocytosis is rare …
Interactions médicamenteuses entre les psychotropes et les thérapies pharmacologiques en oncologie: quelles modalités de prescription?
M Reich, N Kotecki - Psycho-Oncologie, 2015 - search.proquest.com
En oncologie, la prescription des psychotropes peut s' étendre à d'autres indications que les
troubles psychiatriques classiques (anxiété, dépression, confusion mentale, psychose …
troubles psychiatriques classiques (anxiété, dépression, confusion mentale, psychose …
Successful clozapine continuation during chemotherapy for the treatment of malignancy: a case report
MR Overbeeke, MM Beex-Oosterhuis… - International journal of …, 2016 - Springer
Case The need for chemotherapy treatment in a cancer patient who uses clozapine raises a
clinical dilemma because both therapies can cause agranulocytosis. A 45-year-old male …
clinical dilemma because both therapies can cause agranulocytosis. A 45-year-old male …
[PDF][PDF] Manic and nonadherent, with a diagnosis of breast cancer
Ms. A, age 58, is a white female with a history of chronic bipolar I disorder who is being
evaluated as a new patient in an academic psychiatric clinic. Recently, she was diagnosed …
evaluated as a new patient in an academic psychiatric clinic. Recently, she was diagnosed …
Drugs interactions between psychotropics and pharmacological treatments in oncology: Which modalities of prescription?
M Reich, N Kotecki - Psycho-Oncologie, 2015 - Springer
In oncology, the prescription of psychotropic drugs can be extended to other indications
such as classic psychiatric disorders, which includes anxiety, depression, delirium …
such as classic psychiatric disorders, which includes anxiety, depression, delirium …
[PDF][PDF] Therapeutic Advances in Psychopharmacology
Background: Clozapine remains the antipsychotic of choice for refractory schizophrenia.
Given the particular side effects of clozapine including neutropenia and myelosuppression …
Given the particular side effects of clozapine including neutropenia and myelosuppression …